TELETRADER News
9/17, 10:14 PM (Source: TeleTrader)
more TeleTrader news

CDC: Moderna jab best in US against hospitalization

A Centers for Disease Control and Prevention (CDC) study published on Friday found that Moderna's COVID-19 vaccine was more effective at preventing hospitalizations than Pfizer and Johnson & Johnson shots.

The study assessed results of more than 3,600 hospitalized adults from March to mid-August and found that Moderna's shot was 93% effective at preventing hospitalizations, with Pfizer at 88% and Johnson & Johnson at 71%. The gap widened even further four months following full vaccination, when Pfizer's efficacy dropped to 77% while Moderna's only lost 1 percentage point.

Researchers reiterated that all FDA-authorized vaccines provide "substantial protection against COVID-19 hospitalization," and suggested that Moderna's superior results may be due to the higher mRNA content of the jab, the additional week between doses or potential differences in the study groups.

The study did not focus specifically on the Delta variant as it only became dominant in the US in July.

Breaking the News / IB